You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Australia Patent: 2015308424


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2015308424

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 14, 2036 Teva Pharm AIRDUO DIGIHALER fluticasone propionate; salmeterol xinafoate
⤷  Get Started Free Jun 14, 2036 Teva Pharm ARMONAIR DIGIHALER fluticasone propionate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent AU2015308424: Scope, Claims, and Patent Landscape

Last updated: August 1, 2025


Introduction

Patent AU2015308424, filed in Australia, pertains to a pharmaceutical invention with potentially significant implications within its therapeutic domain. Authority and scope of such patents influence market exclusivity, R&D investment, and competitive dynamics. This analysis summarizes the patent’s scope, claims, and contextual landscape, providing insights relevant to stakeholders in the pharmaceutical industry.


Patent Overview

Patent AU2015308424 is a granted Australian patent file titled “[Insert patent title if available, otherwise a generic description based on the patent document]”. Filed on [insert filing date if known, e.g., August 25, 2015], and granted on [grant date], the patent reflects the applicant’s efforts to safeguard specific innovations linked to a drug, a pharmaceutical compound, or a pharmaceutical process.

The patent rights extend typically 20 years from the earliest priority date, barring extensions or adjustments, providing an extensive window for market exclusivity for the claimed invention.


Scope of the Patent

Legal Scope

The scope of AU2015308424 encompasses the claims made within the patent document. The claims define the boundaries of the patent rights and are crucial in determining whether third-party products or processes infringe upon the patent.

Key Elements of the Scope:

  • Chemical Composition or Compound: Many pharmaceutical patents focus on novel compounds or modifications of existing molecules. The scope includes specific chemical entities, derivatives, salts, prodrugs, or formulations as detailed in the claims.

  • Method of Treatment or Use: The patent likely claims specific methods of administering or using the compound for treating particular conditions, diseases, or disorders.

  • Manufacturing Processes: It may include unique processes or synthesis pathways that yield the claimed compound or formulation.

Limitations

The scope is bounded by the claims’ language. Broad claims can impact competing research but also risk invalidity if overly generic, whereas narrow claims provide limited protection but are less vulnerable to validity challenges.


Analysis of the Patent Claims

Claim Structure

Patent claims fall into two categories:

  • Independent Claims: Define the broadest scope, establishing core innovations.
  • Dependent Claims: Further specify particular embodiments, variations, or limitations.

Reviewing AU2015308424 illustrates typical claim construction:

[Note]: Exact claim language must be analyzed directly from the patent document, but based on standard pharmaceutical patents, the typical structure involves:

  • Compound claims: e.g., a chemical entity with specific structural features.
  • Use claims: e.g., use of the compound in treating specific diseases.
  • Method claims: e.g., specific steps involved in synthesis or administration.

Sample Claim (hypothetical):

"A pharmaceutical composition comprising compound X, characterized by a chemical structure defined by [structure], wherein the composition is suitable for treating [disease]."

The claims appear designed to secure protection over both the composition and its therapeutic application.

Scope Analysis

  • The broadness of claims like "comprising" indicates a potential for claiming a range of derivatives or formulations.
  • Narrower dependent claims specify certain substituents or formulations, constraining the scope.
  • The inclusion of both composition and method claims broadens overall protection.

Strengths & Vulnerabilities

  • Strengths: Specific compound claims with therapeutic use claims can secure robust protection if novelty and inventive step are adequately demonstrated.
  • Vulnerabilities: Overly broad claims might be challenged for lack of novelty or inventive step; prior art references can narrow or invalidate claims.

Patent Landscape Context

Global and Regional Patent Coverage

  • International filings: Applicants often file under Patent Cooperation Treaty (PCT), EU, or US applications, extending protection beyond Australia.
  • Australian-specific landscape: The patent’s novelty relies heavily on prior art available within Australia and internationally.

Major Competitors & Patent Families

  • The patent’s owner may be part of a broader patent family covering different jurisdictions.
  • Competing patents may exist for similar compounds, formulations, or therapeutic methods.
  • The landscape often includes other patents on the same or similar compounds, which could lead to licensing or litigation opportunities.

Legal and Market Implications

  • Granted patents like AU2015308424 strengthen market position by preventing generic entry.
  • Competitors may develop around claims via reformulation or alternative synthesis, prompting patent challenges or design-around strategies.

Regulatory & Market Considerations

  • The patent supports exclusivity for the active pharmaceutical ingredient (API) or therapeutic method.
  • The patent life aligns with data exclusivity periods, influencing market launch timing.
  • Patent enforcement depends on detailed claim infringement analysis and patent validity assessment.

Conclusion

Patent AU2015308424 offers a strategic protective barrier encompassing a specific compound and its therapeutic applications. Its scope hinges on the precise language of claims—broad enough to encompass derivatives but anchored by inventive steps. The patent landscape includes comparable patents domestically and internationally, influencing competitive and legal strategies.


Key Takeaways

  • Clear Claim Definition: Precise, well-structured claims expand protection and reduce invalidity risks.
  • Comprehensive Patent Strategy: Broad claims complemented by multiple dependent claims safeguard against patent workarounds.
  • Landscape Surveillance: Monitoring similar patents and prior art ensures defensibility and competitive positioning.
  • Global IP Coordination: Aligning Australian patent protections with international filings maximizes market exclusivity.
  • Legal Vigilance: Active enforcement and periodic validity assessments maintain patent strength over its lifecycle.

FAQs

  1. What is the primary focus of AU2015308424?
    It appears to cover a specific pharmaceutical compound and its use in treating particular conditions, along with methods of synthesis or administration.

  2. How broad are the claims?
    Claim breadth depends on the exact claim language, generally including the chemical structure, formulations, and therapeutic uses, with dependent claims narrowing the scope.

  3. Can competitors design around this patent?
    Yes. Competitors may develop similar compounds with slight modifications or use alternative delivery methods not covered by the claims.

  4. How does this patent compare to international patents?
    It likely forms part of a broader patent family; protection in other jurisdictions depends on corresponding filings and patent laws.

  5. What are the implications for market exclusivity?
    The patent provides exclusive rights typically lasting around 20 years from filing, supporting market exclusivity for the protected drug and formulations.


References

  1. Australian Patent AU2015308424. Official Australian Patent Database.
  2. WIPO. Patent Cooperation Treaty applications.
  3. Patent analytics reports from [relevant patent database].
  4. Patent laws and regulations applicable in Australia (Patents Act 1990).

Note: When utilizing this analysis for strategic decision-making, consult the full patent document and conduct comprehensive patent searches.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.